Tomiki Yuichi, Ono Seigo, Aoki Jun, Takahashi Rina, Ishiyama Shun, Sugimoto Kiichi, Yaginuma Yukihiro, Kojima Yutaka, Goto Michitoshi, Okuzawa Atsushi, Sakamoto Kazuhiro
Department of Coloproctological Surgery, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Diagn Ther Endosc. 2015;2015:517690. doi: 10.1155/2015/517690. Epub 2015 Jul 12.
Objective. A new sclerosing agent for hemorrhoids, aluminum potassium sulfate and tannic acid (ALTA), is attracting attention as a curative treatment for internal hemorrhoids without resection. The outcome and safety of ALTA sclerotherapy using an endoscope were investigated in the present study. Materials and Methods. Subjects comprised 83 internal hemorrhoid patients (61 males and 22 females). An endoscope was inserted and retroflexed in the rectum, and a 1st-step injection was applied to the upper parts of the hemorrhoids. The retroflexed scope was returned to the normal position, and 2nd-4th-step injections were applied to the middle and lower parts of the hemorrhoids under direct vision. The effects of endoscopic ALTA sclerotherapy were determined by evaluating the condition of the hemorrhoids using an anoscope and interviewing the patient 28 days after the treatment. Results. A cure, improvement, and failure were observed in 54 (65.1%), 27 (32.5%), and 2 (2.4%) patients, respectively, treated with ALTA. Complications developed in 4 patients (mild fever in 3 and hematuria in 1). Recurrence occurred in 9.6%. Conclusions. The results of the present study suggest that endoscopic ALTA has the potential to become a useful and minimally invasive approach for ALTA sclerotherapy.
目的。一种新型的痔疮硬化剂,硫酸铝钾和鞣酸(ALTA),作为一种无需切除的内痔治疗方法正受到关注。本研究调查了使用内窥镜进行ALTA硬化治疗的效果和安全性。材料与方法。研究对象包括83例内痔患者(男性61例,女性22例)。将内窥镜插入直肠并进行反转,对痔核上部进行第一步注射。将反转的内窥镜恢复到正常位置,在直视下对痔核的中部和下部进行第二至第四步注射。通过使用肛门镜评估痔核状况并在治疗28天后询问患者来确定内窥镜下ALTA硬化治疗的效果。结果。接受ALTA治疗的患者中,分别有54例(65.1%)治愈、27例(32.5%)改善和2例(2.4%)治疗失败。4例患者出现并发症(3例轻度发热,1例血尿)。复发率为9.6%。结论。本研究结果表明,内窥镜下ALTA硬化治疗有可能成为一种有用的、微创的ALTA硬化治疗方法。